1. Home >
  2. Companies >
  3. Life Science >
  4. Germany >
  5. C3 Cannabinoid Compound

C3 Cannabinoid Compound - Ownership and Business Overview

Life ScienceCompany

C3 Cannabinoid Compound Ownership

Who owns C3 Cannabinoid Compound?

C3 Cannabinoid Compound is owned by Dermapharm Holding SE. It was acquired on December 15, 2021.

C3 Cannabinoid Compound Business Overview

Where is C3 Cannabinoid Compound headquartered?

C3 Cannabinoid Compound is headquartered in Neumarkt, Germany.

What sector is C3 Cannabinoid Compound in?

C3 Cannabinoid Compound is a life science company.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Subscribe to Mergr to view all 400 acquisitions of life science companies in 2021, including 47 acquisitions by private equity firms, and 353 by strategics.

C3 Cannabinoid Compound

C³ Cannabinoid Compound Company GmbH

Kerschensteinerstraße 11-15,
Neumarkt, 92318
Germany,
www.c3-company.de

C3 Cannabinoid Compound develops and manufactures pharmaceutical products and is comprised of Spectrum Therapeutics GmbH, based in Neumarkt-in-der-Oberpfalz, Germany, THC Pharm GmbH The Health Concept, based in Frankfurt, Germany, and Spectrum Therapeutics Austria GmbH, based in Vienna, Austria.


Company Summary

SECTOR

Life Science

Revenue

27   2018
(millions of EUR)

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for C3 Cannabinoid Compound

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal